Epizyme Obtains $8,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=67596a7b-37b6-4f7d-bb42-ef17d61a6c7f&Preview=1 - Date
12/8/2009 - Company Name
Epizyme - Mailing Address
840 Memorial Drive Cambridge, MA 02139 - Company Description
Epizyme is a biopharmaceutical company located in Cambridge, MA. Founded in late 2007, the company has brought together premier academic and industry leaders to rapidly translate the exciting discoveries emerging from epigenetic research into specific programs that will produce important, novel, molecularly targeted drugs of the future. - Website
http://www.epizyme.com - Transaction Type
Venture Equity - Transaction Amount
$8,000,000 - Transaction Round
Series B - Proceeds Purposes
“By raising more capital now, we can continue to aggressively advance our pipeline of histone methyltransferase inhibitors for various oncology indications. I look forward to working with our investors to continue to build a leading company in the promising new area of epigenetics.” - M&A Terms
- Venture Investor
New Enterprise Associates
